MetLife Announces Second Quarter 2015 Results
Second quarter 2015 operating earnings included the following item:
-
a one-time tax rate change in
Japan , which increased operating earnings by\\$61 million , or\\$0.05 per share, after tax
MetLife’s operating return on equity (ROE), excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA)*, was 12.5 percent for the second quarter of 2015, and the company’s tangible operating ROE* was 15.3 percent.
On a GAAP basis,
The second quarter variance between operating earnings and net income
reflects asymmetrical and non-economic accounting of
Premiums, fees & other revenues* were
Book value, excluding AOCI other than FCTA*, was
“MetLife delivered strong double-digit operating earnings growth in the second quarter,” said
Steven A. Kandarian, chairman, president and chief
executive officer of
SECOND QUARTER 2015 SUMMARY |
||||||||||
(\\$ in millions, except per share data) | Three months ended June 30 | |||||||||
2015 | 2014 | Change | ||||||||
Premiums, fees & other revenues | \\$ | 12,175 | \\$ | 12,706 | (4 | %) | ||||
Total operating revenues | \\$ | 17,360 | \\$ | 17,801 | (2 | %) | ||||
Operating earnings | \\$ | 1,765 | \\$ | 1,590 | 11 | % | ||||
Operating earnings per share | \\$ | 1.56 | \\$ | 1.39 | 12 | % | ||||
Net income | \\$ | 1,042 | \\$ | 1,335 | (22 | %) | ||||
Net income per share | \\$ | 0.92 | \\$ | 1.17 | (21 | %) | ||||
Book value per share, excluding AOCI
other than FCTA |
\\$ | 50.73 | \\$ | 48.60 | 4 | % | ||||
Book value per share – tangible common
stockholders’ equity |
\\$ | 41.73 | \\$ | 38.69 | 8 | % | ||||
Book value per share | \\$ | 60.27 | \\$ | 59.96 | 1 | % | ||||
*Information regarding the non-GAAP financial measures included in this news release and the reconciliation of the non-GAAP financial measures to GAAP measures is provided in the Non-GAAP and Other Financial Disclosures discussion below, as well as in the tables that accompany this release and/or the Second Quarter 2015 Financial Supplement (which is available on the MetLife Investor Relations Web page at www.metlife.com).
BUSINESS DISCUSSIONS
All comparisons of the results for the second quarter of 2015 in the business discussions that follow are with the second quarter of 2014, unless otherwise noted.
THE
Total operating earnings for the
Retail
Operating earnings for Retail were
Group, Voluntary & Worksite Benefits
Operating earnings for Group, Voluntary & Worksite Benefits were
Corporate Benefit Funding
Operating earnings for Corporate Benefit Funding were
Operating earnings for
Operating earnings for
EMEA
Operating earnings for EMEA were
INVESTMENTS
Net investment income was
Rising interest rates contributed to derivative net losses of
CORPORATE & OTHER
Corporate & Other had an operating loss of
Conference Call
The conference call will be available for replay via telephone and the
Internet beginning at
A brief video of CFO
John Hele discussing second quarter 2015 results can be viewed at www.metlife.com/earningsvideo.
About
Non-GAAP and Other Financial DisclosuresAny
references in this news release (except in this section and in the
tables that accompany this release) to net income (loss), net income
(loss) per share, operating earnings, operating earnings per share, book
value per share, book value per share, excluding accumulated other
comprehensive income (loss) (AOCI) other than foreign currency
translation adjustments (FCTA), book value per share-tangible common
stockholders’ equity, premiums, fees and other revenues, operating
return on equity, excluding AOCI other than FCTA, and tangible operating
return on equity should be read as net income (loss) available to
Operating earnings is the measure of segment profit or loss that
Operating earnings is defined as operating revenues less operating expenses, both net of income tax. Operating earnings available to common shareholders is defined as operating earnings less preferred stock dividends.
Operating revenues and operating expenses exclude results of
discontinued operations and other businesses that have been or will be
sold or exited by
The following additional adjustments are made to GAAP revenues, in the line items indicated, in calculating operating revenues:
• | Universal life and investment-type product policy fees excludes the amortization of unearned revenue related to NIGL and NDGL and certain variable annuity guaranteed minimum income benefits (GMIB) fees (GMIB fees); | ||
• | Net investment income: (i) includes amounts for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments but do not qualify for hedge accounting treatment, (ii) includes income from discontinued real estate operations, (iii) excludes post-tax operating earnings adjustments relating to insurance joint ventures accounted for under the equity method, (iv) excludes certain amounts related to contractholder-directed unit-linked investments, and (v) excludes certain amounts related to securitization entities that are variable interest entities (VIEs) consolidated under GAAP; and | ||
• | Other revenues are adjusted for settlements of foreign currency earnings hedges. |
The following additional adjustments are made to GAAP expenses, in the line items indicated, in calculating operating expenses:
• | Policyholder benefits and claims and policyholder dividends excludes: (i) changes in the policyholder dividend obligation related to NIGL and NDGL, (ii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass through adjustments, (iii) benefits and hedging costs related to GMIBs (GMIB costs), and (iv) market value adjustments associated with surrenders or terminations of contracts (Market value adjustments); | ||
• | Interest credited to policyholder account balances includes adjustments for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment and excludes amounts related to net investment income earned on contractholder-directed unit-linked investments; | ||
• | Amortization of DAC and value of business acquired (VOBA) excludes amounts related to: (i) NIGL and NDGL, (ii) GMIB fees and GMIB costs and (iii) Market value adjustments; | ||
• | Amortization of negative VOBA excludes amounts related to Market value adjustments; | ||
• | Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and | ||
• | Other expenses excludes costs related to: (i) noncontrolling interests, (ii) implementation of new insurance regulatory requirements, and (iii) acquisition and integration costs. |
Operating earnings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance. In addition to the tax impact of the adjustments mentioned above, provision for income tax (expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax reforms.
Operating return on
Operating return on
Operating return on
Return on
Return on
Return on
Allocated equity is defined as the portion of
Operating return on allocated equity is defined as operating earnings available to common shareholders divided by allocated equity.
Operating return on allocated tangible equity is defined as operating earnings available to common shareholders, excluding amortization of VODA and VOCRA, net of income tax, divided by allocated tangible equity.
Return on allocated equity is defined as net income (loss) available to
Return on allocated tangible equity is defined as net income (loss)
available to
We sometimes refer to sales activity for various products. These sales
statistics do not correspond to revenues under GAAP, but are used as
relevant measures of business activity. Statistical sales information
for life insurance is calculated by
All comparisons on a constant currency basis reflect the impact of changes in foreign currency exchange rates and are calculated using the average foreign currency exchange rates for the current period and are applied to each of the comparable periods.
Asymmetrical and non-economic accounting refer to: (i) the portion of net derivative gains (losses) on embedded derivatives attributable to the inclusion of MetLife’s credit spreads in the liability valuations, (ii) hedging activity that generates net derivative gains (losses) and creates fluctuations in net income because hedge accounting cannot be achieved and the item being hedged does not a have an offsetting gain or loss recognized in earnings, (iii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass through adjustments, and (iv) impact of changes in foreign currency exchange rates on the re-measurement of foreign denominated unhedged funding agreements and financing transactions to the U.S. dollar and the re-measurement of certain liabilities from non-functional currencies to functional currencies.
Operating expense ratio is calculated by dividing operating expenses (other expenses, net of capitalization of DAC) by operating premiums, fees and other revenues.
Forward-Looking Statements
This news release may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning, or are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operations and financial results.
Any or all forward-looking statements may turn out to be wrong. They can
be affected by inaccurate assumptions or by known or unknown risks and
uncertainties. Many such factors will be important in determining the
actual future results of
MetLife, Inc. | ||||||||||||||||||||
Consolidated Statements of Operating Earnings Available to Common Shareholders | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
For the Three Months Ended | For the Six Months Ended | |||||||||||||||||||
June 30, | June 30, | |||||||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||||||
(In millions) | (In millions) | |||||||||||||||||||
OPERATING REVENUES | ||||||||||||||||||||
Premiums | \\$ | 9,313 | \\$ | 9,853 | \\$ | 18,566 | \\$ | 19,070 | ||||||||||||
Universal life and investment-type product policy fees | 2,335 | 2,360 | 4,629 | 4,683 | ||||||||||||||||
Net investment income | 5,185 | 5,095 | 10,167 | 10,180 | ||||||||||||||||
Other revenues | 527 | 493 | 1,030 | 984 | ||||||||||||||||
Total operating revenues | 17,360 | 17,801 | 34,392 | 34,917 | ||||||||||||||||
OPERATING EXPENSES | ||||||||||||||||||||
Policyholder benefits and claims and policyholder dividends | 9,503 | 9,964 | 18,950 | 19,337 | ||||||||||||||||
Interest credited to policyholder account balances | 1,342 | 1,425 | 2,673 | 2,826 | ||||||||||||||||
Capitalization of DAC | (927 | ) | (1,031 | ) | (1,895 | ) | (2,077 | ) | ||||||||||||
Amortization of DAC and VOBA | 1,001 | 1,025 | 1,954 | 2,075 | ||||||||||||||||
Amortization of negative VOBA | (83 | ) | (99 | ) | (173 | ) | (202 | ) | ||||||||||||
Interest expense on debt | 307 | 299 | 604 | 593 | ||||||||||||||||
Other expenses | 3,882 | 3,979 | 7,682 | 7,930 | ||||||||||||||||
Total operating expenses | 15,025 | 15,562 | 29,795 | 30,482 | ||||||||||||||||
Operating earnings before provision for income tax | 2,335 | 2,239 | 4,597 | 4,435 | ||||||||||||||||
Provision for income tax expense (benefit) | 539 | 618 | 1,133 | 1,222 | ||||||||||||||||
Operating earnings | 1,796 | 1,621 | 3,464 | 3,213 | ||||||||||||||||
Preferred stock dividends | 31 | 31 | 61 | 61 | ||||||||||||||||
OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS | \\$ | 1,765 | \\$ | 1,590 | \\$ | 3,403 | \\$ | 3,152 | ||||||||||||
Reconciliation to Net Income (Loss) and Financial Statement Line Item Adjustments from GAAP |
||||||||||||||||||||
Operating earnings | \\$ | 1,796 | \\$ | 1,621 | \\$ | 3,464 | \\$ | 3,213 | ||||||||||||
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: | ||||||||||||||||||||
Net investment gains (losses) (1), (2) | (133 | ) | (125 | ) | 153 | (536 | ) | |||||||||||||
Net derivative gains (losses) (2) | (912 | ) | 311 | (91 | ) | 654 | ||||||||||||||
Premiums | (1 | ) | 20 | (1 | ) | 22 | ||||||||||||||
Universal life and investment-type product policy fees | 99 | 98 | 199 | 196 | ||||||||||||||||
Net investment income | (238 | ) | 164 | 241 | 114 | |||||||||||||||
Other revenues | (9 | ) | (3 | ) | (17 | ) | (16 | ) | ||||||||||||
Policyholder benefits and claims and policyholder dividends (2) | (180 | ) | (421 | ) | (329 | ) | (675 | ) | ||||||||||||
Interest credited to policyholder account balances | 44 | (284 | ) | (620 | ) | (352 | ) | |||||||||||||
Capitalization of DAC | - | 1 | - | 1 | ||||||||||||||||
Amortization of DAC and VOBA (2) | 104 | (37 | ) | 32 | (45 | ) | ||||||||||||||
Amortization of negative VOBA | 9 | 12 | 19 | 24 | ||||||||||||||||
Interest expense on debt | (1 | ) | (13 | ) | (2 | ) | (31 | ) | ||||||||||||
Other expenses | (4 | ) | (12 | ) | (9 | ) | (15 | ) | ||||||||||||
Goodwill impairment | - | - | - | - | ||||||||||||||||
Provision for income tax (expense) benefit (2) | 545 | 44 | 243 | 164 | ||||||||||||||||
Income (loss) from continuing operations, net of income tax | 1,119 | 1,376 | 3,282 | 2,718 | ||||||||||||||||
Income (loss) from discontinued operations, net of income tax | - | - | - | (3 | ) | |||||||||||||||
Net income (loss) | 1,119 | 1,376 | 3,282 | 2,715 | ||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 4 | 10 | 9 | 21 | ||||||||||||||||
Net income (loss) attributable to MetLife, Inc. | 1,115 | 1,366 | 3,273 | 2,694 | ||||||||||||||||
Less: Preferred stock dividends | 31 | 31 | 61 | 61 | ||||||||||||||||
Less: Preferred stock repurchase premium | 42 | - | 42 | - | ||||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | 1,042 | \\$ | 1,335 | \\$ | 3,170 | \\$ | 2,633 | ||||||||||||
See footnotes on last page. | ||||||||||||||||||||
MetLife, Inc. | |||||||||||||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||||||||||||
For the Three Months Ended | For the Six Months Ended | ||||||||||||||||||||||||||||||||||||
June 30, | June 30, | ||||||||||||||||||||||||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||||||||||||||||||||||
Earnings Per Weighted Average Common Shares
Diluted |
Earnings Per Weighted Average Common Shares
Diluted |
Earnings Per Weighted Average Common Shares Diluted |
Earnings Per Weighted Average Common Shares
Diluted |
||||||||||||||||||||||||||||||||||
(In millions, except per share data) | (In millions, except per share data) | ||||||||||||||||||||||||||||||||||||
Reconciliation to Net Income (Loss) Available to MetLife, Inc.'s Common Shareholders |
|||||||||||||||||||||||||||||||||||||
Operating earnings available to common shareholders | \\$ | 1,765 | \\$ | 1.56 | \\$ | 1,590 | \\$ | 1.39 | \\$ | 3,403 | \\$ | 3.01 | \\$ | 3,152 | \\$ | 2.76 | |||||||||||||||||||||
Adjustments from operating earnings available to common shareholders to net income (loss) available | |||||||||||||||||||||||||||||||||||||
to MetLife, Inc.'s common shareholders: | |||||||||||||||||||||||||||||||||||||
Add: Net investment gains (losses) (1) | (133 | ) | (0.12 | ) | (125 | ) | (0.11 | ) | 153 | 0.14 | (536 | ) | (0.47 | ) | |||||||||||||||||||||||
Add: Net derivative gains (losses) | (912 | ) | (0.81 | ) | 311 | 0.27 | (91 | ) | (0.08 | ) | 654 | 0.57 | |||||||||||||||||||||||||
Add: Goodwill impairment | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||
Add: Other adjustments to continuing operations | (177 | ) | (0.15 | ) | (475 | ) | (0.41 | ) | (487 | ) | (0.43 | ) | (777 | ) | (0.67 | ) | |||||||||||||||||||||
Add: Provision for income tax (expense) benefit | 545 | 0.48 | 44 | 0.04 | 243 | 0.21 | 164 | 0.14 | |||||||||||||||||||||||||||||
Add: Income (loss) from discontinued operations, net of income tax | - | - | - | - | - | - | (3 | ) | - | ||||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 4 | - | 10 | 0.01 | 9 | 0.01 | 21 | 0.02 | |||||||||||||||||||||||||||||
Less: Preferred stock repurchase premium | 42 | 0.04 | - | - | 42 | 0.04 | - | - | |||||||||||||||||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | 1,042 | \\$ | 0.92 | \\$ | 1,335 | \\$ | 1.17 | \\$ | 3,170 | \\$ | 2.80 | \\$ | 2,633 | \\$ | 2.31 | |||||||||||||||||||||
Weighted average common shares outstanding - diluted | 1128.4 | 1142.3 | 1131.1 | 1140.8 | |||||||||||||||||||||||||||||||||
For the Three Months Ended | For the Six Months Ended | ||||||||||||||||||||||||||||||||||||
June 30, | June 30, | ||||||||||||||||||||||||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||||||||||||||||||||||
(In millions) | (In millions) | ||||||||||||||||||||||||||||||||||||
Reconciliation to GAAP Premiums, Fees and Other Revenues |
|||||||||||||||||||||||||||||||||||||
Total operating premiums, fees and other revenues | \\$ | 12,175 | \\$ | 12,706 | \\$ | 24,225 | \\$ | 24,737 | |||||||||||||||||||||||||||||
Add: Adjustments to premiums, fees and other revenues | 89 | 115 | 181 | 202 | |||||||||||||||||||||||||||||||||
Total premiums, fees and other revenues | \\$ | 12,264 | \\$ | 12,821 | \\$ | 24,406 | \\$ | 24,939 | |||||||||||||||||||||||||||||
Reconciliation to GAAP Revenues and GAAP Expenses |
|||||||||||||||||||||||||||||||||||||
Total operating revenues | \\$ | 17,360 | \\$ | 17,801 | \\$ | 34,392 | \\$ | 34,917 | |||||||||||||||||||||||||||||
Add: Net investment gains (losses) (1) | (133 | ) | (125 | ) | 153 | (536 | ) | ||||||||||||||||||||||||||||||
Add: Net derivative gains (losses) | (912 | ) | 311 | (91 | ) | 654 | |||||||||||||||||||||||||||||||
Add: Adjustments related to net investment gains (losses) and net derivative gains (losses) | 3 | 3 | 7 | 6 | |||||||||||||||||||||||||||||||||
Add: Other adjustments to revenues | (152 | ) | 276 | 415 | 310 | ||||||||||||||||||||||||||||||||
Total revenues | \\$ | 16,166 | \\$ | 18,266 | \\$ | 34,876 | \\$ | 35,351 | |||||||||||||||||||||||||||||
Total operating expenses | \\$ | 15,025 | \\$ | 15,562 | \\$ | 29,795 | \\$ | 30,482 | |||||||||||||||||||||||||||||
Add: Adjustments related to net investment gains (losses) and net derivative gains (losses) | (94 | ) | 63 | 1 | 64 | ||||||||||||||||||||||||||||||||
Add: Goodwill impairment | - | - | - | - | |||||||||||||||||||||||||||||||||
Add: Other adjustments to expenses | 122 | 691 | 908 | 1,029 | |||||||||||||||||||||||||||||||||
Total expenses | \\$ | 15,053 | \\$ | 16,316 | \\$ | 30,704 | \\$ | 31,575 | |||||||||||||||||||||||||||||
See footnotes on last page. | |||||||||||||||||||||||||||||||||||||
MetLife, Inc. | |||||||||||||||||
(Unaudited) | |||||||||||||||||
June 30, | |||||||||||||||||
Book Value (3) | 2015 | 2014 | |||||||||||||||
Book value per common share | \\$ | 60.27 | \\$ | 59.96 | |||||||||||||
Less: Net unrealized investment gains (losses), net of income tax | 11.52 | 12.77 | |||||||||||||||
Less: Defined benefit plans adjustment, net of income tax | (1.98 | ) | (1.41 | ) | |||||||||||||
Book value per common share, excluding AOCI other than FCTA | \\$ | 50.73 | \\$ | 48.60 | |||||||||||||
Less: Goodwill, net of income tax | 8.51 | 9.19 | |||||||||||||||
Less: VODA and VOCRA, net of income tax | 0.49 | 0.72 | |||||||||||||||
Book value per common share - tangible common stockholders' equity (excludes AOCI other than FCTA) | \\$ | 41.73 | \\$ | 38.69 | |||||||||||||
Common shares outstanding, end of period (In millions) | 1,116.8 | 1,126.6 | |||||||||||||||
For the Three Months Ended | For the Year Ended | ||||||||||||||||
June 30, | December 31, | ||||||||||||||||
Return on Equity (4) | 2015 | 2014 | 2014 | ||||||||||||||
Operating return on MetLife, Inc.'s: | |||||||||||||||||
Common stockholders' equity | 10.2 | % | 9.7 | % | 10.0 | % | |||||||||||
Common stockholders' equity, excluding AOCI other than FCTA | 12.5 | % | 11.7 | % | 12.0 | % | |||||||||||
Tangible common stockholders' equity (excludes AOCI other than FCTA) | 15.3 | % | 14.9 | % | 15.2 | % | |||||||||||
Return on MetLife, Inc.'s: | |||||||||||||||||
Common stockholders' equity | 6.0 | % | 8.1 | % | 9.4 | % | |||||||||||
Common stockholders' equity, excluding AOCI other than FCTA | 7.4 | % | 9.9 | % | 11.3 | % | |||||||||||
Tangible common stockholders' equity (excludes AOCI other than FCTA) | 9.1 | % | 12.5 | % | 14.3 | % | |||||||||||
Operating return on allocated equity: | |||||||||||||||||
Americas | 14.8 | % | 14.8 | % | |||||||||||||
Asia | 14.8 | % | 11.1 | % | |||||||||||||
EMEA | 6.0 | % | 8.3 | % | |||||||||||||
Operating return on allocated tangible equity: | |||||||||||||||||
Americas | 16.6 | % | 16.9 | % | |||||||||||||
Asia | 25.4 | % | 19.2 | % | |||||||||||||
EMEA | 11.2 | % | 16.1 | % | |||||||||||||
Return on allocated equity: | |||||||||||||||||
Americas | 10.4 | % | 12.8 | % | |||||||||||||
Asia | 19.6 | % | 11.4 | % | |||||||||||||
EMEA | 7.7 | % | 13.2 | % | |||||||||||||
Return on Allocated Tangible Equity: | |||||||||||||||||
Americas | 11.7 | % | 14.6 | % | |||||||||||||
Asia | 33.7 | % | 19.7 | % | |||||||||||||
EMEA | 14.2 | % | 25.2 | % | |||||||||||||
See footnotes on last page. | |||||||||||||||||
MetLife, Inc. | ||||||||||||||||||||
Reconciliations to Net Income (Loss) Available to Common Shareholders | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
For the Three Months Ended | For the Six Months Ended | |||||||||||||||||||
June 30, | June 30, | |||||||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||||||
(In millions) | (In millions) | |||||||||||||||||||
Total Americas Operations: | ||||||||||||||||||||
Operating earnings available to common shareholders | \\$ | 1,443 | \\$ | 1,385 | \\$ | 2,824 | \\$ | 2,709 | ||||||||||||
Add: Net investment gains (losses) (1) | (14 | ) | (189 | ) | 260 | (706 | ) | |||||||||||||
Add: Net derivative gains (losses) | (508 | ) | 429 | 69 | 715 | |||||||||||||||
Add: Other adjustments to continuing operations | (124 | ) | (484 | ) | (392 | ) | (759 | ) | ||||||||||||
Add: Provision for income tax (expense) benefit | 221 | 62 | 16 | 231 | ||||||||||||||||
Add: Income (loss) from discontinued operations, net of income tax | - | - | - | (3 | ) | |||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 3 | 4 | 6 | 9 | ||||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | 1,015 | \\$ | 1,199 | \\$ | 2,771 | \\$ | 2,178 | ||||||||||||
Retail: | ||||||||||||||||||||
Operating earnings available to common shareholders | \\$ | 690 | \\$ | 677 | \\$ | 1,343 | \\$ | 1,313 | ||||||||||||
Add: Net investment gains (losses) | 9 | 10 | 77 | 16 | ||||||||||||||||
Add: Net derivative gains (losses) | (95 | ) | 225 | 218 | 296 | |||||||||||||||
Add: Other adjustments to continuing operations | (72 | ) | (274 | ) | (264 | ) | (421 | ) | ||||||||||||
Add: Provision for income tax (expense) benefit | 55 | 14 | (11 | ) | 39 | |||||||||||||||
Add: Income (loss) from discontinued operations, net of income tax | - | - | - | (2 | ) | |||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | 587 | \\$ | 652 | \\$ | 1,363 | \\$ | 1,241 | ||||||||||||
Group, Voluntary & Worksite Benefits: | ||||||||||||||||||||
Operating earnings available to common shareholders | \\$ | 231 | \\$ | 209 | \\$ | 459 | \\$ | 399 | ||||||||||||
Add: Net investment gains (losses) | 8 | 10 | 11 | (1 | ) | |||||||||||||||
Add: Net derivative gains (losses) | (264 | ) | 71 | (59 | ) | 187 | ||||||||||||||
Add: Other adjustments to continuing operations | (41 | ) | (42 | ) | (83 | ) | (81 | ) | ||||||||||||
Add: Provision for income tax (expense) benefit | 104 | (14 | ) | 46 | (37 | ) | ||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | 38 | \\$ | 234 | \\$ | 374 | \\$ | 467 | ||||||||||||
Corporate Benefit Funding: | ||||||||||||||||||||
Operating earnings available to common shareholders | \\$ | 406 | \\$ | 363 | \\$ | 775 | \\$ | 703 | ||||||||||||
Add: Net investment gains (losses) | (31 | ) | (195 | ) | 174 | (736 | ) | |||||||||||||
Add: Net derivative gains (losses) (1) | (134 | ) | 125 | (54 | ) | 228 | ||||||||||||||
Add: Other adjustments to continuing operations | 13 | (22 | ) | (26 | ) | (24 | ) | |||||||||||||
Add: Provision for income tax (expense) benefit | 53 | 24 | (33 | ) | 172 | |||||||||||||||
Add: Income (loss) from discontinued operations, net of income tax | - | - | - | (1 | ) | |||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | 307 | \\$ | 295 | \\$ | 836 | \\$ | 342 | ||||||||||||
Latin America: | ||||||||||||||||||||
Operating earnings available to common shareholders | \\$ | 116 | \\$ | 136 | \\$ | 247 | \\$ | 294 | ||||||||||||
Add: Net investment gains (losses) | - | (14 | ) | (2 | ) | 15 | ||||||||||||||
Add: Net derivative gains (losses) | (15 | ) | 8 | (36 | ) | 4 | ||||||||||||||
Add: Other adjustments to continuing operations | (24 | ) | (146 | ) | (19 | ) | (233 | ) | ||||||||||||
Add: Provision for income tax (expense) benefit | 9 | 38 | 14 | 57 | ||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 3 | 4 | 6 | 9 | ||||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | 83 | \\$ | 18 | \\$ | 198 | \\$ | 128 | ||||||||||||
Asia: | ||||||||||||||||||||
Operating earnings available to common shareholders | \\$ | 425 | \\$ | 324 | \\$ | 752 | \\$ | 657 | ||||||||||||
Add: Net investment gains (losses) | 57 | 82 | 125 | 239 | ||||||||||||||||
Add: Net derivative gains (losses) | 9 | (35 | ) | 27 | (42 | ) | ||||||||||||||
Add: Other adjustments to continuing operations | (37 | ) | (6 | ) | (92 | ) | (18 | ) | ||||||||||||
Add: Provision for income tax (expense) benefit | 111 | (27 | ) | 101 | (68 | ) | ||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 1 | 4 | 1 | 10 | ||||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | 564 | \\$ | 334 | \\$ | 912 | \\$ | 758 | ||||||||||||
EMEA: | ||||||||||||||||||||
Operating earnings available to common shareholders | \\$ | 50 | \\$ | 72 | \\$ | 120 | \\$ | 143 | ||||||||||||
Add: Net investment gains (losses) | 5 | 2 | 8 | (7 | ) | |||||||||||||||
Add: Net derivative gains (losses) | 13 | 49 | 14 | 87 | ||||||||||||||||
Add: Other adjustments to continuing operations | (12 | ) | 31 | 7 | 30 | |||||||||||||||
Add: Provision for income tax (expense) benefit | 7 | (38 | ) | (19 | ) | (51 | ) | |||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | (1 | ) | 1 | 1 | 1 | |||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | 64 | \\$ | 115 | \\$ | 129 | \\$ | 201 | ||||||||||||
Corporate & Other: | ||||||||||||||||||||
Operating earnings available to common shareholders | \\$ | (153 | ) | \\$ | (191 | ) | \\$ | (293 | ) | \\$ | (357 | ) | ||||||||
Add: Net investment gains (losses) | (181 | ) | (20 | ) | (240 | ) | (62 | ) | ||||||||||||
Add: Net derivative gains (losses) | (426 | ) | (132 | ) | (201 | ) | (106 | ) | ||||||||||||
Add: Other adjustments to continuing operations | (4 | ) | (16 | ) | (10 | ) | (30 | ) | ||||||||||||
Add: Provision for income tax (expense) benefit | 206 | 47 | 145 | 52 | ||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 1 | 1 | 1 | 1 | ||||||||||||||||
Less: Preferred stock repurchase premium | 42 | - | 42 | - | ||||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | (601 | ) | \\$ | (313 | ) | \\$ | (642 | ) | \\$ | (504 | ) | ||||||||
See footnotes on last page. | ||||||||||||||||||||
MetLife, Inc. | ||||||||||||||||||||
GAAP Interim Condensed Consolidated Statements of Operations | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
For the Three Months Ended | For the Six Months Ended | |||||||||||||||||||
June 30, | June 30, | |||||||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||||||
(In millions) | (In millions) | |||||||||||||||||||
Revenues | ||||||||||||||||||||
Premiums | \\$ | 9,312 | \\$ | 9,873 | \\$ | 18,565 | \\$ | 19,092 | ||||||||||||
Universal life and investment-type product policy fees | 2,434 | 2,458 | 4,828 | 4,879 | ||||||||||||||||
Net investment income | 4,947 | 5,259 | 10,408 | 10,294 | ||||||||||||||||
Other revenues | 518 | 490 | 1,013 | 968 | ||||||||||||||||
Net investment gains (losses): | ||||||||||||||||||||
Other-than-temporary impairments on fixed maturity securities | - | (9 | ) | (8 | ) | (23 | ) | |||||||||||||
Other-than-temporary impairments on fixed maturity securities | ||||||||||||||||||||
transferred to other comprehensive income (loss) | (2 | ) | (6 | ) | (12 | ) | (2 | ) | ||||||||||||
Other net investment gains (losses) (1) | (131 | ) | (110 | ) | 173 | (511 | ) | |||||||||||||
Total net investment gains (losses) | (133 | ) | (125 | ) | 153 | (536 | ) | |||||||||||||
Net derivative gains (losses) | (912 | ) | 311 | (91 | ) | 654 | ||||||||||||||
Total revenues | 16,166 | 18,266 | 34,876 | 35,351 | ||||||||||||||||
Expenses | ||||||||||||||||||||
Policyholder benefits and claims | 9,352 | 9,988 | 18,609 | 19,312 | ||||||||||||||||
Interest credited to policyholder account balances | 1,298 | 1,709 | 3,293 | 3,178 | ||||||||||||||||
Policyholder dividends | 331 | 397 | 670 | 700 | ||||||||||||||||
Other expenses | 4,072 | 4,222 | 8,132 | 8,385 | ||||||||||||||||
Total expenses | 15,053 | 16,316 | 30,704 | 31,575 | ||||||||||||||||
Income (loss) from continuing operations before provision for income tax | 1,113 | 1,950 | 4,172 | 3,776 | ||||||||||||||||
Provision for income tax expense (benefit) | (6 | ) | 574 | 890 | 1,058 | |||||||||||||||
Income (loss) from continuing operations, net of income tax | 1,119 | 1,376 | 3,282 | 2,718 | ||||||||||||||||
Income (loss) from discontinued operations, net of income tax | - | - | - | (3 | ) | |||||||||||||||
Net income (loss) | 1,119 | 1,376 | 3,282 | 2,715 | ||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 4 | 10 | 9 | 21 | ||||||||||||||||
Net income (loss) attributable to MetLife, Inc. | 1,115 | 1,366 | 3,273 | 2,694 | ||||||||||||||||
Less: Preferred stock dividends | 31 | 31 | 61 | 61 | ||||||||||||||||
Preferred stock repurchase premium | 42 | - | 42 | - | ||||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders | \\$ | 1,042 | \\$ | 1,335 | \\$ | 3,170 | \\$ | 2,633 | ||||||||||||
(1) | The three months and six months ended June 30, 2014 include a pre-tax net investment loss of \\$138 million and \\$633 million, respectively, related to the sale of MetLife, Inc.'s wholly-owned subsidiary, MetLife Assurance Limited. | |
(2) | The impacts of asymmetrical and non-economic accounting for the three months ended June 30, 2015 are as follows: i) Net investment gains (losses) - (\\$199) million; ii) Net derivative gains (losses) - (\\$1,192) million; iii) Policyholder benefits and claims and policyholder dividends - \\$25 million; iv) Amortization of DAC and VOBA - \\$48 million; and v) Provision for income tax (expense) benefit - \\$462 million. | |
(3) | Book values exclude \\$2,066 million and \\$2,043 million of equity related to preferred stock at June 30, 2015 and 2014, respectively. | |
(4) | Annualized using quarter-to-date results. |
Êîììåíòàðèè